Evolvere BioSciences
PrivateLast Round
Accelerator
Aug 23, 2024
Total Funding Raised
$500,000
Company Overview
Evolvere BioSciences is a biotechnology company that develops a therapeutics platform to combat antimicrobial resistance by creating next-generation antibiotics using AI-powered computational models.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evolvere BioSciences Comparables
Compare Evolvere BioSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glox Therapeutics | 78% | |
| A-Alpha Bio | 66% | |
| Ailurus Biotechnology | 66% | |
Evolvere BioSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 23, 2024 |
Evolvere BioSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
Evolvere BioSciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evolvere BioSciences's valuation, stock price, and market status.